Skip to content

‘Bizarre’ Potential $7.1 Billion Tax Bill Sinks Amgen Shares

  • Shares fall as much as 7% after latest tax disclosure
  • Fines are ‘bizarre,’ but likely worst-case scenario: analyst
Updated on

Shares of Amgen Inc. fell the most in a year after the company disclosed that it is facing a potential tax bill of at least $7.1 billion from the U.S. Internal Revenue Service.

The IRS is seeking $5.1 billion in back taxes related to how profit was allocated between Amgen’s entities in Puerto Rico and in the mainland U.S. for the years 2013 to 2015, in addition to about $2 billion in penalties. The drugmaker disclosed the news with its first-quarter results on Wednesday, and it largely overshadowed better-than-expected revenue and earnings.